ADIPOQ and cancer: In this context, our finding that adiponectin regulates osteoclast activity and differentiation in bone further strengthens the argument that a metabolic pathway driven by adiponectin controls many osteoimmunology processes, including remodeling of bone marrow hematopoietic stem cell niche, with potential implications for multiple human disease states including cancer.